Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Perro

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Virulence|November 30, 2020
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infectionMario Perro, Matteo Iannacone, Ulrich H von Andrian, et al.
Lancet (London, England)|October 12, 2010
Infant colitis--it's in the genesErik-Oliver Glocker, Natalie Frede, Mario Perro, et al.
International Journal of Cancer|October 26, 2007
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative proteinAnnalisa Lorenzato, Martina Olivero, Mario Perro, et al.
Scientific Reports|October 5, 2016
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodiesCapucine L Grandjean, Fabricio Montalvao, Susanna Celli, et al.
Nature|April 25, 2014
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammationLorena Riol-Blanco, Jose Ordovas-Montanes, Mario Perro, et al.
Plos One|January 6, 2021
Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine modelFloriana Cremasco, Elena Menietti, Dario Speziale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus ModelAnthony D Marinov, Haowei Wang, Sheldon I Bastacky, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Frontiers in Immunology|August 23, 2021
Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor ImmunityCaleb R Stoltzfus, Ramya Sivakumar, Leo Kunz, et al.
Blood Cells, Molecules & Diseases|September 15, 2007
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cellsHans J Stauss, Sharyn Thomas, Michela Cesco-Gaspere, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Virulence|November 30, 2020
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infectionMario Perro, Matteo Iannacone, Ulrich H von Andrian, et al.
Lancet (London, England)|October 12, 2010
Infant colitis--it's in the genesErik-Oliver Glocker, Natalie Frede, Mario Perro, et al.
International Journal of Cancer|October 26, 2007
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative proteinAnnalisa Lorenzato, Martina Olivero, Mario Perro, et al.
Scientific Reports|October 5, 2016
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodiesCapucine L Grandjean, Fabricio Montalvao, Susanna Celli, et al.
Nature|April 25, 2014
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammationLorena Riol-Blanco, Jose Ordovas-Montanes, Mario Perro, et al.
Plos One|January 6, 2021
Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine modelFloriana Cremasco, Elena Menietti, Dario Speziale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus ModelAnthony D Marinov, Haowei Wang, Sheldon I Bastacky, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Frontiers in Immunology|August 23, 2021
Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor ImmunityCaleb R Stoltzfus, Ramya Sivakumar, Leo Kunz, et al.
Blood Cells, Molecules & Diseases|September 15, 2007
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cellsHans J Stauss, Sharyn Thomas, Michela Cesco-Gaspere, et al.
Pageof 4